These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention. Feldman DN; Wong SC; Bergman G; Minutello RM J Invasive Cardiol; 2009 Jun; 21(6):258-63. PubMed ID: 19494400 [TBL] [Abstract][Full Text] [Related]
15. [Intracoronary administration of antithrombotic agents via a perfusion balloon catheter in patients with ST-segment elevation myocardial infarction presenting with massive intraluminal thrombus and failed aspiration]. Ajlani B; Gibault-Genty G; Cherif G; Blicq E; Azzaz S; Schiano P; Brami M; Sarfati L; Charbonnel C; Convers-Domart R; Livarek B; Georges JL Ann Cardiol Angeiol (Paris); 2016 Nov; 65(5):299-305. PubMed ID: 27693166 [TBL] [Abstract][Full Text] [Related]
16. Antiplatelet intervention in acute coronary syndrome. Arora RR; Rai F Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648 [TBL] [Abstract][Full Text] [Related]
17. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Stone GW; White HD; Ohman EM; Bertrand ME; Lincoff AM; McLaurin BT; Cox DA; Pocock SJ; Ware JH; Feit F; Colombo A; Manoukian SV; Lansky AJ; Mehran R; Moses JW; Lancet; 2007 Mar; 369(9565):907-19. PubMed ID: 17368152 [TBL] [Abstract][Full Text] [Related]
18. Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes. Collet JP; Montalescot G; Golmard JL; Tanguy ML; Ankri A; Choussat R; Beygui F; Drobinski G; Vignolles N; Thomas D Am Heart J; 2004 Apr; 147(4):655-61. PubMed ID: 15077081 [TBL] [Abstract][Full Text] [Related]
19. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis. Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes. Jennings LK; Saucedo JF Curr Opin Cardiol; 2008 Jul; 23(4):302-8. PubMed ID: 18520712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]